Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways

被引:21
作者
Aarbio, J
van Schadewijk, A
Stolk, J
Sont, JK
de Boer, WI
Rabe, KF
van Krieken, JHJM
Mauad, T
Hiemstra, PS
机构
[1] Leiden Univ Med Ctr, Dept Pulmonol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
squamous metaplasia; airway epithelium; antimicrobial peptides; proliferation; airways obstruction;
D O I
10.1007/s00011-003-1240-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective:The aim of this study was to analyze a possible contribution of human neutrophil defensins and secretory leukocyte proteinase inhibitor (SLPI) to the induction of airway epithelial changes such as squamous cell metaplasia. Materials and methods:The presence of these molecules and the number of proliferating (Ki-67-positive) epithelial cells was analyzed by immunohistochemistry in bronchial epithelium from subjects with (n=15) or without (n=14) chronic obstructive pulmonary disease (COPD). Results:Our data demonstrate higher numbers of defensin-positive (p=0.0001), elastase-positive (p=0.0001) and Ki-67-positive (p=0.0001) cells in areas with squamous cell metaplasia as compared to areas with intact or damaged epithelium, while the reverse was observed for SLPI expression (p=0.002). No differences were observed between subjects with or without COPD, nor between current smokers and those that had stopped smoking. Conclusions:These data are in line with a role of defensins in the hyperproliferative phenotype of squamous metaplastic lesions in the airways. This role does not seem to be restricted to patients with COPD.
引用
收藏
页码:230 / 238
页数:9
相关论文
共 39 条
[1]   Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro [J].
Aarbiou, J ;
Verhoosel, RM ;
van Wetering, S ;
de Boer, WI ;
van Krieken, JHJM ;
Litvinov, SV ;
Rabe, KF ;
Hiemstra, PS .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 30 (02) :193-201
[2]  
Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167
[3]   Role of defensins in inflammatory lung disease [J].
Aarbiou, J ;
Rabe, KF ;
Hiemstra, PS .
ANNALS OF MEDICINE, 2002, 34 (02) :96-101
[4]  
Ameshima S, 2000, CANCER-AM CANCER SOC, V89, P1448, DOI 10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO
[5]  
2-Q
[6]   A MORPHOLOGIC STUDY OF LUNG SECRETORY LEUKOPROTEASE INHIBITOR IN PNEUMONIA [J].
ASANO, S ;
KIDA, K ;
KOYAMA, T ;
WADA, H ;
IZAWA, Y ;
HOSODA, K ;
MASUDA, K ;
SUZUKI, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) :1576-1581
[7]   Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing [J].
Ashcroft, GS ;
Lei, KJ ;
Jin, WW ;
Longenecker, G ;
Kulkarni, AB ;
Greenwell-Wild, T ;
Hale-Donze, H ;
McGrady, G ;
Song, XY ;
Wahl, SM .
NATURE MEDICINE, 2000, 6 (10) :1147-1153
[8]   Identification of defensins in human lymphocyte nuclei [J].
Blomqvist, M ;
Bergquist, J ;
Westman, A ;
Håkansson, K ;
Håkansson, P ;
Fredman, P ;
Ekman, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (02) :312-318
[9]   CHARACTERIZATION OF THE INFLAMMATORY REACTION IN THE PERIPHERAL AIRWAYS OF CIGARETTE SMOKERS USING IMMUNOCYTOCHEMISTRY [J].
BOSKEN, CH ;
HARDS, J ;
GATTER, K ;
HOGG, JC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (04) :911-917
[10]   Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells [J].
Devoogdt, N ;
Ghassabeh, GH ;
Zhang, J ;
Brys, L ;
De Baetselier, P ;
Revets, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :5778-5782